Cargando…
Applying Serum Cytokine Levels to Predict Pain Severity in Cancer Patients
BACKGROUND AND AIM: Cancers originating in the breast, lung and prostate often metastasize to the bone, frequently resulting in cancer-induced bone pain that can be challenging to manage despite conventional analgesic therapy. This exploratory study’s aim was to identify potential biomarkers associa...
Autores principales: | Fazzari, Jennifer, Sidhu, Jesse, Motkur, Shreya, Inman, Mark, Buckley, Norman, Clemons, Mark, Vandermeer, Lisa, Singh, Gurmit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012636/ https://www.ncbi.nlm.nih.gov/pubmed/32104053 http://dx.doi.org/10.2147/JPR.S227175 |
Ejemplares similares
-
Effect of glutaminase inhibition on cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2019) -
Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Meta-bolism to Peripheral Sensory Pain Pathways
por: Fazzari, Jennifer, et al.
Publicado: (2017) -
Identification of capsazepine as a novel inhibitor of system x(c)(−) and cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2017) -
Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer
por: Zhao, Huijun, et al.
Publicado: (2023) -
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain
por: Fazzari, Jennifer, et al.
Publicado: (2015)